Iovance Biotherapeutics Inc Cash Flow-to-Debt Ratio
Iovance Biotherapeutics Inc cash flow-to-debt ratio. Iovance Biotherapeutics Inc (IOVA) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of $-78.70 Million could theoretically repay 0% of its total liabilities ($202.66 Million) in one year. Check Iovance Biotherapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Iovance Biotherapeutics Inc (2008–2024)
Cash flow-to-debt ratio of Iovance Biotherapeutics Inc from 2008 to 2024. Historical debt coverage capacity for Iovance Biotherapeutics Inc across 17 annual periods. Check Iovance Biotherapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Iovance Biotherapeutics Inc Cash Flow-to-Debt Ratio by Year (2008–2024)
Iovance Biotherapeutics Inc cash flow-to-debt ratio by year from 2008 to 2024. Year-by-year debt coverage analysis for Iovance Biotherapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Iovance Biotherapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.76x | $-352.98 Million | $200.02 Million | ▲ +4.5% |
| 2023 | -1.85x | $-361.82 Million | $195.74 Million | ▼ -3.8% |
| 2022 | -1.78x | $-292.76 Million | $164.34 Million | ▼ -21.7% |
| 2021 | -1.46x | $-227.94 Million | $155.67 Million | ▲ +20.1% |
| 2020 | -1.83x | $-205.13 Million | $111.96 Million | ▲ +47.3% |
| 2019 | -3.48x | $-158.89 Million | $45.68 Million | ▲ +49.8% |
| 2018 | -6.92x | $-101.25 Million | $14.63 Million | ▲ +13.0% |
| 2017 | -7.96x | $-78.71 Million | $9.89 Million | ▼ -21.0% |
| 2016 | -6.58x | $-32.67 Million | $4.97 Million | ▲ +41.7% |
| 2015 | -11.28x | $-18.38 Million | $1.63 Million | ▼ -117.1% |
| 2014 | -5.20x | $-8.63 Million | $1.66 Million | ▼ -222.0% |
| 2013 | -1.61x | $-3.66 Million | $2.27 Million | ▼ -716.9% |
| 2012 | -0.20x | $-2.24 Million | $11.35 Million | ▲ +57.4% |
| 2011 | -0.46x | $-6.19 Million | $13.35 Million | ▲ +38.5% |
| 2010 | -0.75x | $-620.80K | $822.87K | ▼ -20.7% |
| 2009 | -0.62x | $-14.45K | $23.12K | ▲ +96.4% |
| 2008 | -17.22x | $-57.30K | $3.33K | — |